Cytokinetics reported $66.85M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 119.6M 23.54M
Acorda Therapeutics ACOR:US $ 46M 8.02M
Amgen AMGN:US $ 12886M 702M
Arca Biopharma ABIO:US $ 3.5M 0.62M
Bayer BAYN:GR € 31019M 1616M
Biogen BIIB:US $ 3946.6M 351.6M
Brainstorm Cell Therapeutics BCLI:US $ 7.37M 1.06M
Bristol Myers Squibb BMY:US $ 22821M 953M
Capricor Therapeutics CAPR:US $ 14.32M 10.19M
Cytokinetics CYTK:US $ 66.85M 5.01M
Eisai 4523:JP Y 313333M 8340M
Eli Lilly And LLY:US $ 13386M 1666.7M
Exelixis EXEL:US $ 289.08M 48.51M
Genocea Biosciences GNCA:US $ 18.03M 0.65M
Geron GERN:US $ 46.63M 1.11M
Halozyme Therapeutics HALO:US $ 111.69M 5.46M
Intra Cellular Therapies ITCI:US $ 59.07M 5.72M
Ligand Pharmaceuticals LGND:US $ 42.58M 0.91M
Merk MRK:US $ 22316M 1556M
Novartis NOVN:VX SF 29807M 401M
Pfizer PFE:US $ 39268M 3403M
Regeneron Pharmaceuticals REGN:US $ 3007.6M 924.9M